Identification of Dihydrofuro[3,4-<i>d</i>]pyrimidine Derivatives as Novel HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors with Promising Antiviral Activities and Desirable Physicochemical Properties
Dongwei Kang(Shandong University), Xinyong Liu(Shandong University of Traditional Chinese Medicine), Christophe Pannecouque(Rega Institute for Medical Research), Tiziana Ginex(Universitat de Barcelona), Erik De Clercq(Rega Institute for Medical Research), Gaochan Wu(Shandong University), F. Javier Luque(Universidad Complutense de Madrid), Fenju Wei(Shandong University), Peng Zhan(Shandong University of Traditional Chinese Medicine), Heng Zhang(Shandong University), Yang Yang(University of Science and Technology of China), Zhao Wang(Shandong University), N. Arul Murugan(AlbaNova), Da Feng(Shandong University), Chin Ho Chen, Kuo‐Hsiung Lee(University of North Carolina at Chapel Hill), Tong Zhao(China Pharmaceutical University), Thomas A. Steitz(Yale University)
Cited by 87
Related Papers
Therapeutic strategies for COVID-19: progress and lessons learned
|Nature Reviews Drug Discovery|2023|671
Antiviral agents active against influenza A viruses
|Nature Reviews Drug Discovery|2006|666
COVID-19: Drug Targets and Potential Treatments
|Journal of Medicinal Chemistry|2020|469
Toward Improved Description of DNA Backbone: Revisiting Epsilon and Zeta Torsion Force Field Parameters
|Journal of Chemical Theory and Computation|2013|287
Design, Synthesis, and Biological Evaluation of Dual Binding Site Acetylcholinesterase Inhibitors: New Disease-Modifying Agents for Alzheimer's Disease
|Journal of Medicinal Chemistry|2005|221